<DOC>
	<DOCNO>NCT00716131</DOCNO>
	<brief_summary>Despite significant progress identification mechanism involve motor neuron degeneration Amyotrophic Lateral Sclerosis ( ALS ) motor system diseases , actual pathogenesis cause diseases remain unknown . Effective treatment disease dependent elucidation cause . The availability diseased control human tissue critical resource research progress . . Samples serum , spinal fluid , urine patient motor system disease use study biochemical genetic difference compare tissue neurologic disease control normal control . Furthermore , availability autopsied CNS , PNS , well tissue patient ALS suspect ALS useful current future research study disease . Therefore , propose institute Tissue Bank contain blood , urine , cerebrospinal fluid donate ALS motor neuron disease patient , also neurologic disease normal whose tissue use control . In addition autopsy band post-mortem specimen ALS motor neuron disease patient . Each specimen , whether live patient autopsy de-identified accompanied standard set clinical information collect medical record order specimen characterize relevant clinical information maximize usefulness specimen . Once establish , tissue bank provide resource large number sample readily available expedite research circumventing delay collect specimen prospectively . These specimen use research ALS Center Hope Drexel University College Medicine share outside investigator valid IRB approve protocol .</brief_summary>
	<brief_title>Amyotrophic Lateral Sclerosis ( ALS ) Tissue Donation Program</brief_title>
	<detailed_description>Despite significant progress identification mechanism involve motor neuron degeneration Amyotrophic Lateral Sclerosis ( ALS ) motor system diseases , actual pathogenesis cause diseases remain unknown . Effective treatment disease dependent elucidation cause . The availability diseased control human tissue critical resource research progress . . Samples serum , spinal fluid , urine patient motor system disease use study biochemical genetic difference compare tissue neurologic disease control normal control . Furthermore , availability autopsied CNS , PNS , well tissue patient ALS suspect ALS useful current future research study disease . Therefore , propose institute Tissue Bank contain blood , urine , cerebrospinal fluid donate ALS motor neuron disease patient , also neurologic disease normal whose tissue use control . In addition autopsy band post-mortem specimen ALS motor neuron disease patient . Each specimen , whether live patient autopsy de-identified accompanied standard set clinical information collect medical record order specimen characterize relevant clinical information maximize usefulness specimen . Once establish , tissue bank provide resource large number sample readily available expedite research circumventing delay collect specimen prospectively . These specimen use research ALS Center Hope Drexel University College Medicine share outside investigator valid IRB approve protocol .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Neurodegenerative Diseases</mesh_term>
	<criteria>Diagnosed ALS motor system disorder include PLS , Bulbar Palsy Motor neuropathy Diagnosed chronic neurologic illness ( Alzheimers , multiple sclerosis , migraine , etc ) Normal Controls In case spinal fluid collection , patient undergo diagnostic lumbar puncture part workup Any person nonneurologic chronic poorly control systemic illness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Amyotrophic Lateral Sclerosis</keyword>
	<keyword>Cerebrospinal Fluid</keyword>
	<keyword>Neurodegenerative Disease</keyword>
	<keyword>Motor Neuron Disease</keyword>
	<keyword>Autonomic Nervous System</keyword>
	<keyword>Neurodegenerative Diseases</keyword>
	<keyword>Movement Disorders</keyword>
</DOC>